<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28422133</article-id>
<article-id pub-id-type="pmc">5520067</article-id>
<article-id pub-id-type="pii">ejhg201755</article-id>
<article-id pub-id-type="doi">10.1038/ejhg.2017.55</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gene-set analysis shows association between FMRP targets and autism spectrum
disorder</article-title>
<alt-title alt-title-type="running">Genetic pathways in autism spectrum disorder</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jansen</surname>
<given-names>Arija</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6733-9023</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dieleman</surname>
<given-names>Gwen C</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smit</surname>
<given-names>August B</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verhage</surname>
<given-names>Matthijs</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verhulst</surname>
<given-names>Frank C</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Polderman</surname>
<given-names>Tinca J C</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Posthuma</surname>
<given-names>Danielle</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Complex Trait Genetics,
Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU
University</institution>, Amsterdam, <country>The Netherlands</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Child and Adolescent
Psychiatry and Psychology, Erasmus University Medical Center-Sophia
Children’s Hospital</institution>, Rotterdam, <country>The
Netherlands</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Molecular and Cellular
Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam
Neuroscience, VU University</institution>, Amsterdam, <country>The
Netherlands</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Clinical Genetics, VU
University Medical Center,</institution>
Amsterdam Neuroscience, Amsterdam, <country>The Netherlands</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Complex Trait Genetics, Center for
Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU
University</institution>, Amsterdam, <country>The Netherlands</country>,
W&amp;N Building, Room B-652, De Boelelaan 1085, 1081
HV
Amsterdam, <country>The Netherlands</country>; Tel: +31 20 598 9898, Fax: +31
02 598 7112; E-mail: <email>a.g.jansen@vu.nl</email></corresp>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>07</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>04</month>
<year>2017</year>
</pub-date>
<volume>25</volume>
<issue>7</issue>
<fpage>863</fpage>
<lpage>868</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>03</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Macmillan Publishers Limited, part of Springer Nature.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Macmillan Publishers Limited, part of Springer Nature.</copyright-holder>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) is a heterogeneous group of disorders characterized by
problems with social interaction, communication, and repetitive and restricted
behavior. Despite its high heritability and the substantial progress made in
elucidating genetic associations, the corresponding biological mechanisms are largely
unknown. Our objective is to investigate the contribution of common genetic variation
to biological pathways functionally involved in ASD. We conducted gene-set analyses
to identify ASD-associated functional biological pathways using the statistical tools
MAGMA and INRICH. Gene-set selection was based on previously reported associations
with psychiatric disorders and resulted in testing of specific synaptic and glial
sets, a glutamate pathway gene-set, mitochondrial gene-sets and gene-sets consisting
of fragile X mental retardation protein (FMRP) targets. In total 32 gene-sets were
tested. We used Psychiatric Genomics Consortium genome-wide association studies
summary statistics of ASD. The study is based on the largest ASD sample to date
(<italic>N</italic>=5305). We found one significantly associated gene-set
consisting of FMRP-targeting transcripts (MAGMA: <italic>p</italic>
<italic>corr.</italic>=0.014, INRICH: <italic>p corr.</italic>=0.031; all competitive
<italic>P</italic>-values). The results indicate the involvement of FMRP-targeted
transcripts in ASD in common genetic variation. This novel finding is in line with
the literature as FMRP has been linked to fragile X syndrome, ASD and cognitive
development in whole-exome sequencing and copy number variant studies. This gene-set
has also been linked to Schizophrenia suggesting that FMRP-targeted transcripts might
be involved in a general mechanism with shared genetic etiology between psychiatric
disorders.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>